Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas

Gynecologic Oncology

Volumn 88, Issue 2, 2003, Pages 123-129

  Baykal, Cem ^a,b   Ayhan, Ayşe ^a   Al, Atakan ^a   Yüce, Kunter ^a   Ayhan, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Apt No 37/9 ^*  (Turkey)

Author keywords

c Met HGFR overexpression; Cervix cancer; Immunohistochemistry; Prognosis; Survival

Indexed keywords

SCATTER FACTOR RECEPTOR;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; EARLY CANCER; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONCOGENE; ONCOGENE C MET; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STAINING; TREATMENT OUTCOME; UNDIFFERENTIATED CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 0037331996     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(02)00073-2     Document Type: Article

References (47)

1. Nakamura T., Teramoto H., Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA. 83:1986;6489-6493.
2. Weidner K.M., Arakaki N., Hartmann G., Vandekerckhove J., Weingart S., Rieder H., Fonatsch C., Tsubouchi H., Hishida T., Daikuhara Y. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA. 88:1991;7001-7005.
3. Tsarfaty I., Resau J.H., Rulong S., Keydar I., Faletto D.L., Vande Woude G.F. The met proto-oncogene receptor and lumen formation. Science. 257:1992;1258-1261.
4. Montesano R., Matsumoto K., Nakamura T., Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 67:1991;901-908.
5. Naldini L., Vigna E., Narsimhan R.P., Gaudino G., Zarnegar R., Michalopoulos G.K., Comoglio P.M. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene. 6:1991;501-504.
6. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Vande Woude G.F., Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 251:1991;802-804.
7. Park M., Dean M., Kaul K., Braun M.J., Gonda M.A., Vande Woude G. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA. 84:1987;6379-6383.
8. Tempest P.R., Stratton M.R., Cooper C.S. Structure of the met protein and variation of met protein kinase activity among human tumour cell lines. Br J Cancer. 58:1988;3-7.
9. Giordano S., Ponzetto C., Di Renzo M.F., Cooper C.S., Comoglio P.M. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature. 339:1989;155-156.
10. Prat M., Narsimhan R.P., Crepaldi T., Nicotra M.R., Natali P.G., Comoglio P.M. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer. 49:1991;323-328.
11. Di Renzo M.F., Olivero M., Ferro S., Prat M., Bongarzone I., Pilotti S., Belfiore A., Costantino A., Vigneri R., Pierotti M.A. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene. 7:1992;2549-2553.
12. Di Renzo M.F., Poulsom R., Olivero M., Comoglio P.M., Lemoine N.R. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res. 55:1995;1129-1138.
13. Ebert M., Yokoyama M., Friess H., Buchler M.W., Korc M. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res. 54:1994;5775-5778.
14. Joseph A., Weiss G.H., Jin L., Fuchs A., Chowdhury S., O'Shaugnessy P., Goldberg I.D., Rosen E.M. Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst. 87:1995;372-377.
15. Humphrey P.A., Zhu X., Zarnegar R., Swanson P.E., Ratliff T.L., Vollmer R.T., Day M.L. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol. 147:1995;386-396.
16. Pisters L.L., Troncoso P., Zhau H.E., Li W., von Eschenbach A.C., Chung L.W. c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol. 154:1995;293-298.
17. Ueki T., Fujimoto J., Suzuki T., Yamamoto H., Okamoto E. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Hepatology. 25:1997;619-623.
18. Umeki K., Shiota G., Kawasaki H. Clinical significance of c-met oncogene alterations in human colorectal cancer. Oncology. 56:1999;314-321.
19. Welch W.C., Kornblith P.L., Michalopoulos G.K., Petersen B.E., Beedle A., Gollin S.M., Goldfarb R.H. Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells. Anticancer Res. 19:1999;1635-1640.
20. Beviglia L., Matsumoto K., Lin C.S., Ziober B.L., Kramer R.H. Expression of the c-Met/HGF receptor in human breast carcinoma correlation with tumor progression . Int J Cancer. 74:1997;301-309.
21. Natali P.G., Prat M., Nicotra M.R., Bigotti A., Olivero M., Comoglio P.M., Di Renzo M.F. Overexpression of the met/HGF receptor in renal cell carcinomas. Int J Cancer. 69:1996;212-217.
22. Tamatani T., Hattori K., Iyer A., Tamatani K., Oyasu R. Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro. Carcinogenesis. 20:1999;957-962.
23. Ayhan A., Baykal C., Al A. Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma. Gynecol Oncol. 83:2001;569-574.
24. Ertoy D., Ayhan A., Sarac E., Karaagaoglu E., Yasui W., Tahara E. Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas. Eur J Cancer. 36:2000;1002-1007.
25. Mathur S.P., Mathur R.S., Rust P.F., Young R.C. Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN). Am J Reprod Immunol. 46:2001;280-287.
26. Ngan H.Y., Cheung A.N., Liu S.S., Liu K.L., Tsao S.W. Telomerase assay and HPV 16/18 typing as adjunct to conventional cytological cervical cancer screening. Tumour Biol. 23:2002;87-92.
27. Leung T.W., Cheung A.N., Cheng D.K., Wong L.C., Ngan H.Y. Expressions of c-erbB-2, epidermal growth factor receptor and pan-ras proto-oncogenes in adenocarcinoma of the cervix correlation with clinical prognosis . Oncol Rep. 8:2001;1159-1164.
28. Kim J.W., Kim Y.T., Kim D.K., Song C.H., Lee J.W. Expression of epidermal growth factor receptor in carcinoma of the cervix. Gynecol Oncol. 60:1996;283-287.
29. Oh M.J., Choi J.H., Kim I.H., Lee Y.H., Huh J.Y., Park Y.K., Lee K.W., Chough S.Y., Joo K.S., Ku B.S., Saw H.S. Detection of epidermal growth factor receptor in the serum of patients with cervical carcinoma. Clin Cancer Res. 6:2000;4760-4763.
30. Biesterfeld S., Schuh S., Muys L., Rath W., Mittermayer C., Schroder W. Absence of epidermal growth factor receptor expression in squamous cell carcinoma of the uterine cervix is an indicator of limited tumor disease. Oncol Rep. 6:1999;205-209.
31. Chang J.L., Tsao Y.P., Liu D.W., Han C.P., Lee W.H., Chen S.L. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix. Gynecol Oncol. 73:1999;62-71.
32. Steller M.A., Delgado C.H., Bartels C.J., Woodworth C.D., Zou Z. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells. Cancer Res. 56:1996;1761-1765.
33. Berger A.J., Baege A., Guillemette T., Deeds J., Meyer R., Disbrow G., Schlegel R. Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins. Am J Pathol. 161:2002;603-610.
34. Cheng W.F., Chen C.A., Lee C.N., Chen T.M., Hsieh F.J., Hsieh C.Y. Vascular endothelial growth factor in cervical carcinoma. Obstet Gynecol. 93:1999;761-765.
35. Hashimoto I., Kodama J., Seki N., Hongo A., Yoshinouchi M., Okuda H., Kudo T. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer. 85:2001;93-97.
36. Ueda M., Terai Y., Yamashita Y., Kumagai K., Ueki K., Yamaguchi H., Akise D., Hung Y.C., Ueki M. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas. Int J Cancer. 98:2002;335-343.
37. Kim J.W., Kim Y.T., Kim D.K. Correlation between EGFR and c-erbB-2 oncoprotein status and response to neoadjuvant chemotherapy in cervical carcinoma. Yonsei Med J. 40:1999;207-214.
38. Bachtiary B., Selzer E., Knocke T.H., Potter R., Obermair A. Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer impact on progression-free survival . Cancer Lett. 179:2002;197-203.
39. Miller A.C., Luo L., Chin W.K., Director-Myska A.E., Prasanna P.G., Blakely W.F. Proto-oncogene expression a predictive assay for radiation biodosimetry applications . Radiat Prot Dosimetry. 99:2002;295-302.
40. Lopez-Ocejo O., Viloria-Petit A., Bequet-Romero M., Mukhopadhyay D., Rak J., Kerbel R.S. Oncogenes and tumor angiogenesis the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner . Oncogene. 19:2000;4611-4620.
41. Suzuki M., Kobayashi H., Kanayama N., Nishida T., Takigawa M., Terao T. CD44 stimulation by fragmented hyaluronic acid induces upregulation and tyrosine phosphorylation of c-Met receptor protein in human chondrosarcoma cells. Biochim Biophys Acta. 1591:2002;37-44.
42. Day R.M., Soon L., Breckenridge D., Bridges B., Patel B.K., Wang L.M., Corey S.J., Bottaro D.P. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways. Oncogene. 21:2002;2201-2211.
43. Giordano S., Zhen Z., Medico E., Gaudino G., Galimi F., Comoglio P.M. Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene. Proc Natl Acad Sci USA. 90:1993;649-653.
44. Shimabukuro K., Ichinose S., Koike R., Kubota T., Yamaguchi M., Miyasaka M., Aso T. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer. Gynecol Oncol. 83:2001;205-215.
45. Wagatsuma S., Konno R., Sato S., Yajima A. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer. 82:1998;520-530.
46. Rong S., Bodescot M., Blair D., Dunn J., Nakamura T., Mizuno K., Park M., Chan A., Aaronson S., Vande Woude G.F. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol. 12:1992;5152-5158.
47. Cortesina G., Martone T., Galeazzi E., Olivero M., De Stefani A., Bussi M., Valente G., Comoglio P.M., Di Renzo M.F. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int J Cancer. 89:2000;286-292.